Holen Sie sich die Stockscreener-App
21.54
2.57%
0.54
Handel nachbörslich:
21.54
Oculis Holding Ag Aktie (OCS) Neueste Nachrichten
Why Oculis Holding AG Equity Warrant stock could outperform in 20252025 Market Trends & Detailed Earnings Play Alerts - newser.com
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewswire
Published on: 2025-10-14 14:36:24 - newser.com
Oculis Holding AG Highlights Innovative Late-Stage Pipeline at Eyecelerator and AAO Annual Meeting - Quiver Quantitative
Privosegtor advancing to registrational trials — Oculis spotlights late-stage pipeline at AAO 2025 - Stock Titan
Will Oculis Holding AG stock gain from strong economyTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
Will Oculis Holding AG stock recover after recent dropMarket Movers & High Accuracy Buy Signal Tips - newser.com
What recovery options are there for Oculis Holding AGMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com
Published on: 2025-10-14 01:25:56 - newser.com
Is Oculis Holding AG stock ready for a breakoutDay Trade & Daily Profit Focused Screening - newser.com
Why Oculis Holding AG Equity Warrant stock remains undervalued2025 Trading Recap & Fast Gaining Stock Strategy Reports - newser.com
What’s the recovery path for long term holders of Oculis Holding AGJuly 2025 Opening Moves & Weekly High Return Stock Forecasts - newser.com
Oculis Holding AG Equity Warrant’s volatility index tracking explained2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
Using data tools to time your Oculis Holding AG Equity Warrant exitGlobal Markets & Expert Approved Trade Ideas - newser.com
How Oculis Holding AG stock compares to industry benchmarksRisk Management & Real-Time Buy Signal Alerts - newser.com
Live market analysis of Oculis Holding AG Equity WarrantJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com
Leading vs lagging indicators on Oculis Holding AG performanceEarnings Risk Report & Precise Trade Entry Recommendations - newser.com
Chardan Capital Issues Positive Estimate for Oculis Earnings - MarketBeat
Risk adjusted return profile for Oculis Holding AG analyzedPrice Action & Low Drawdown Momentum Ideas - newser.com
Using RSI to spot recovery in Oculis Holding AG Equity Warrant2025 Trading Recap & Low Risk High Reward Ideas - newser.com
Will Oculis Holding AG Equity Warrant price bounce be sustainableJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com
Sentiment analysis tools applied to Oculis Holding AGMarket Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Oculis Holding (NasdaqGM:OCS): Evaluating Valuation Following PIONEER Clinical Program Launch and FDA Meeting - Sahm
Why Oculis Holding AG (CR5) stock is favored by hedge fundsIPO Watch & Long-Term Capital Growth Strategies - newser.com
Chart based analysis of Oculis Holding AG trendsJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock? - Nasdaq
Oculis' (OCS) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Is Oculis Holding AG Equity Warrant stock entering bullish territoryJuly 2025 Drop Watch & Verified Technical Trade Signals - newser.com
Price action breakdown for Oculis Holding AG Equity WarrantEarnings Recap Summary & Consistent Return Investment Signals - newser.com
Will Oculis Holding AG (CR5) stock benefit from sector leadershipIPO Watch & Accurate Technical Buy Alerts - newser.com
Chardan Capital Forecasts Strong Price Appreciation for Oculis (NASDAQ:OCS) Stock - Defense World
Oculis Holding AG Equity Warrant stock momentum explainedFed Meeting & Daily Growth Stock Tips - newser.com
What recovery options are there for Oculis Holding AG Equity Warrant - newser.com
What to expect from Oculis Holding AG in the next 30 daysTrade Signal Summary & Smart Swing Trading Alerts - newser.com
Can volume confirm reversal in Oculis Holding AG2025 Price Momentum & Reliable Trade Execution Plans - newser.com
Applying chart zones and confluence areas to Oculis Holding AG Equity Warrant2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
Why Oculis (OCS) Is Up 14.2% After Advancing Privosegtor Into FDA-Backed PIONEER Trials - Sahm
Oculis (NASDAQ:OCS) Sees Large Volume Increase Following Analyst Upgrade - Defense World
Chardan Research Adjusts Oculis Holding AG Price Target to $51 From $33, Maintains Buy Rating - MarketScreener
Oculis (NASDAQ:OCS) Price Target Raised to $51.00 - MarketBeat
Chardan Capital Maintains Oculis Holding (OCS) Buy Recommendation - Nasdaq
HC Wainwright Issues Positive Forecast for Oculis (NASDAQ:OCS) Stock Price - Defense World
Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume After Analyst Upgrade - MarketBeat
Oculis (NASDAQ:OCS) Given New $36.00 Price Target at HC Wainwright - MarketBeat
HC Wainwright & Co. Maintains Oculis Holding (OCS) Buy Recommendation - Nasdaq
Oculis stock price target raised to $36 from $33 at H.C. Wainwright - Investing.com
Oculis to launch PIONEER trials for privosegtor in acute optic neuritis and NAION - Ophthalmology Times
Oculis Advances Privosegtor into Registrational Trials for Neuro-Ophthalmology - TipRanks
Does Oculis Holding AG Equity Warrant show high probability of reboundJuly 2025 Rallies & Community Supported Trade Ideas - newser.com
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):